Evolus Stock Based Compensation from 2010 to 2024

EOLS Stock

USD 12.67 0.07 0.56%

Evolus Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2016-12-31

Previous Quarter

5.8 M

Current Value

5.2 M

Quarterly Volatility

1.5 M

Covid

Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 M, Interest Expense of 14.5 M or Selling General Administrative of 81.7 M, as well as many indicators such as Price To Sales Ratio of 4.6, Dividend Yield of 0.0 or Days Sales Outstanding of 74.33. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.

Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Evolus Inc over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Evolus' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Evolus Stock Based Compensation Regression Statistics

	Arithmetic Mean	6,122,793
	Geometric Mean	3,490,980
	Coefficient Of Variation	95.87
	Mean Deviation	5,114,846
	Median	1,513,000
	Standard Deviation	5,870,157
	Sample Variance	34.5T
	Range	16.7M
	R-Value	0.89
	Mean Square Error	7.5T
	R-Squared	0.80
	Slope	1,171,908
	Total Sum of Squares	482.4T

Evolus Stock Based Compensation History

	2024	17.3 M
	2023	16.5 M
	2022	10.8 M
	2021	9.6 M
	2020	10.6 M
	2019	9.5 M
	2018	7 M

Other Fundumenentals of Evolus Inc

Stock Based Compensation To Revenue

Evolus Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Good Will	Short Term Investments	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Capital Surpluse	Net Receivables	Net Invested Capital	Net Working Capital	Long Term Debt	Capital Stock	Common Stock	Long Term Debt Total	Property Plant Equipment	Current Deferred Revenue
Total Assets		-0.77	0.3	-0.36	-0.76	0.78	-0.27	0.61	0.77	-0.93	0.55	1.0	-0.28	-0.39	0.85	-0.91	-0.22	0.89	0.75	-0.27	-0.27	-0.65	-0.63	0.53
Total Stockholder Equity	-0.77		-0.13	0.43	0.36	-0.6	-0.15	-0.14	-0.61	0.59	-0.29	-0.77	0.06	-0.04	-0.44	0.67	0.07	-0.53	-0.3	-0.15	-0.15	0.34	0.32	-0.06
Net Tangible Assets	0.3	-0.13		-0.82	-0.13	0.03	-0.01	0.29	-0.37	-0.15	-0.32	0.3	-0.79	-0.08	0.22	-0.4	0.37	0.63	0.32	-0.01	-0.01	0.0	-0.33	0.24
Net Debt	-0.36	0.43	-0.82		0.19	-0.31	-0.16	-0.14	0.21	0.18	0.45	-0.37	0.81	-0.01	-0.19	0.57	-0.03	-0.6	-0.2	-0.16	-0.16	0.11	0.27	-0.11
Retained Earnings	-0.76	0.36	-0.13	0.19		-0.81	0.62	-0.91	-0.7	0.77	-0.37	-0.76	0.44	0.84	-0.9	0.76	0.55	-0.74	-0.86	0.62	0.62	0.97	0.86	-0.89
Accounts Payable	0.78	-0.6	0.03	-0.31	-0.81		-0.18	0.54	0.73	-0.73	0.27	0.78	-0.33	-0.43	0.72	-0.81	-0.51	0.66	0.66	-0.18	-0.18	-0.73	-0.57	0.52
Good Will	-0.27	-0.15	-0.01	-0.16	0.62	-0.18		-0.69	-0.3	0.35	-0.25	-0.25	0.29	0.81	-0.4	0.29	0.38	-0.32	-0.54	1.0	1.0	0.68	0.49	-0.63
Short Term Investments	0.61	-0.14	0.29	-0.14	-0.91	0.54	-0.69		0.46	-0.64	0.35	0.61	-0.45	-0.93	0.85	-0.56	-0.34	0.68	0.8	-0.69	-0.69	-0.88	-0.95	0.97
Total Liab	0.77	-0.61	-0.37	0.21	-0.7	0.73	-0.3	0.46		-0.81	0.74	0.77	0.22	-0.39	0.74	-0.62	-0.49	0.46	0.58	-0.3	-0.3	-0.68	-0.45	0.44
Deferred Long Term Liab	-0.93	0.59	-0.15	0.18	0.77	-0.73	0.35	-0.64	-0.81		-0.72	-0.93	0.15	0.48	-0.9	0.88	0.42	-0.84	-0.7	0.35	0.35	0.66	0.58	-0.56
Short Long Term Debt	0.55	-0.29	-0.32	0.45	-0.37	0.27	-0.25	0.35	0.74	-0.72		0.55	0.52	-0.27	0.59	-0.33	-0.19	0.32	0.31	-0.25	-0.25	-0.31	-0.26	0.28
Total Current Assets	1.0	-0.77	0.3	-0.37	-0.76	0.78	-0.25	0.61	0.77	-0.93	0.55		-0.28	-0.39	0.86	-0.91	-0.23	0.89	0.75	-0.25	-0.25	-0.65	-0.65	0.54
Short Term Debt	-0.28	0.06	-0.79	0.81	0.44	-0.33	0.29	-0.45	0.22	0.15	0.52	-0.28		0.36	-0.28	0.51	0.08	-0.61	-0.5	0.29	0.29	0.36	0.45	-0.45
Intangible Assets	-0.39	-0.04	-0.08	-0.01	0.84	-0.43	0.81	-0.93	-0.39	0.48	-0.27	-0.39	0.36		-0.68	0.4	0.52	-0.45	-0.62	0.81	0.81	0.89	0.84	-0.91
Capital Surpluse	0.85	-0.44	0.22	-0.19	-0.9	0.72	-0.4	0.85	0.74	-0.9	0.59	0.86	-0.28	-0.68		-0.78	-0.4	0.82	0.84	-0.4	-0.4	-0.81	-0.83	0.84
Net Receivables	-0.91	0.67	-0.4	0.57	0.76	-0.81	0.29	-0.56	-0.62	0.88	-0.33	-0.91	0.51	0.4	-0.78		0.43	-0.92	-0.69	0.29	0.29	0.65	0.55	-0.49
Net Invested Capital	-0.22	0.07	0.37	-0.03	0.55	-0.51	0.38	-0.34	-0.49	0.42	-0.19	-0.23	0.08	0.52	-0.4	0.43		-0.16	-0.18	0.38	0.38	0.62	0.24	-0.37
Net Working Capital	0.89	-0.53	0.63	-0.6	-0.74	0.66	-0.32	0.68	0.46	-0.84	0.32	0.89	-0.61	-0.45	0.82	-0.92	-0.16		0.79	-0.32	-0.32	-0.58	-0.66	0.61
Long Term Debt	0.75	-0.3	0.32	-0.2	-0.86	0.66	-0.54	0.8	0.58	-0.7	0.31	0.75	-0.5	-0.62	0.84	-0.69	-0.18	0.79		-0.54	-0.54	-0.76	-0.75	0.82
Capital Stock	-0.27	-0.15	-0.01	-0.16	0.62	-0.18	1.0	-0.69	-0.3	0.35	-0.25	-0.25	0.29	0.81	-0.4	0.29	0.38	-0.32	-0.54		1.0	0.68	0.49	-0.63
Common Stock	-0.27	-0.15	-0.01	-0.16	0.62	-0.18	1.0	-0.69	-0.3	0.35	-0.25	-0.25	0.29	0.81	-0.4	0.29	0.38	-0.32	-0.54	1.0		0.68	0.49	-0.63
Long Term Debt Total	-0.65	0.34	0.0	0.11	0.97	-0.73	0.68	-0.88	-0.68	0.66	-0.31	-0.65	0.36	0.89	-0.81	0.65	0.62	-0.58	-0.76	0.68	0.68		0.85	-0.87
Property Plant Equipment	-0.63	0.32	-0.33	0.27	0.86	-0.57	0.49	-0.95	-0.45	0.58	-0.26	-0.65	0.45	0.84	-0.83	0.55	0.24	-0.66	-0.75	0.49	0.49	0.85		-0.93
Current Deferred Revenue	0.53	-0.06	0.24	-0.11	-0.89	0.52	-0.63	0.97	0.44	-0.56	0.28	0.54	-0.45	-0.91	0.84	-0.49	-0.37	0.61	0.82	-0.63	-0.63	-0.87	-0.93

Click cells to compare fundamentals

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	16.5 M	17.3 M
Stock Based Compensation To Revenue	0.08	0.15

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Evolus Stock Based Compensation from 2010 to 2024

Latest Evolus' Stock Based Compensation Growth Pattern

Evolus Stock Based Compensation Regression Statistics

Evolus Stock Based Compensation History

Other Fundumenentals of Evolus Inc

Evolus Stock Based Compensation component correlations

About Evolus Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Evolus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY